| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| LANNETT CO INC | Director | Common stock | 93.3K | $75.5K | $0.81 | Sep 14, 2022 | Direct |
| Arbutus Biopharma Corp | Director | Stock Option (Right to Buy) | 67K | May 23, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ABUS | Arbutus Biopharma Corp | May 23, 2024 | 1 | $0 | 4 | May 24, 2024 | Director |
| ABUS | Arbutus Biopharma Corp | Jul 12, 2023 | 1 | $0 | 4 | Jul 13, 2023 | Director |
| ABUS | Arbutus Biopharma Corp | Jul 12, 2023 | 0 | $0 | 3 | Jul 13, 2023 | Director |
| LCI | LANNETT CO INC | Sep 14, 2022 | 1 | $15.3K | 4 | Sep 15, 2022 | Director |
| LCI | LANNETT CO INC | Sep 9, 2021 | 1 | -$80.6K | 4 | Sep 13, 2021 | Director |
| LCI | LANNETT CO INC | Aug 31, 2021 | 1 | $0 | 4 | Sep 2, 2021 | Director |
| LCI | LANNETT CO INC | Sep 3, 2020 | 1 | -$75.3K | 4 | Jun 10, 2021 | Director |